Treatment of circulating neoplastic cells

Area of Science:

• Developmental Biology
• Oncology
• Hematology

Background:

• Ontogeny involves increasing tissue and organ integration, particularly in mammals due to their complex body fluid systems.
• Developed mammals exhibit specialized structures like bone marrow and lymphatic systems, predisposing them to diverse leukemias, which are considered systemic diseases.
• Leukemias are classified by abnormal cell type and disease duration (acute vs. chronic).

Purpose of the Study:

• To elucidate the mechanisms of cell dissemination in neoplastic progression.
• To differentiate between systemic leukemias and solid tumor metastasis.
• To introduce and define carcinocythemia as a process of detecting circulating tumor cells.

Main Methods:

• Comparative analysis of cell dissemination in leukemias and solid tumors.
• Review of German literature on leukemia classification and characteristics.
• Description of cellular pathways for metastasis via lymphatic and vascular systems.

Main Results:

• Leukemias are characterized by pathologically underdeveloped, uniformly distributed cells.
• Motile tumor cells from solid tumors can enter circulation via lymphatics or blood vessels, leading to distant spread (carcinocythemia).
• Non-movable tumor cells spread directly within veins, maintaining connection to the primary tumor, as seen in renal cell carcinoma.

Conclusions:

• Mammalian development involves complex integration systems that influence disease pathology, including leukemia and metastasis.
• Understanding cell motility and dissemination pathways is crucial for diagnosing and treating various cancers.
• Carcinocythemia represents a distinct mechanism of tumor cell spread compared to direct venous invasion.